Latest stories on MYGN
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
Business Insider58 · neutralproduct/pr
Myriad Genetics: Prenatal Sale Provides A Lifeline In A Tough Spot
Seeking Alpha42 · neutralgeneral
TD says Myriad Genetics prenatal divestiture proceeds ahead of expectations
The Fly63 · neutralgeneral
TD Cowen holds Myriad Genetics stock rating on Labcorp sale
Investing.com Analyst Ratings52 · neutralanalyst
Myriad Genetics upgraded to Neutral from Underweight at Piper Sandler
The Fly63 · neutralanalyst
Myriad Genetics stock surges on $210M prenatal unit sale
Investing.com Markets74 · bullishm&a
MYGN jumps as Myriad agrees to sell Prenatal Health testing business to Labcorp for $210 million cash
MarketChameleon64 · neutralm&a
Myriad to sell prenatal health testing business to Labcorp for $210M
Seeking Alpha64 · neutralm&a
Why is Myriad Genetics stock surging today?
Investing.com Markets64 · neutralgeneral
Labcorp Buying Myriad Genetics' Prenatal Health Testing Business for $210 Million
MarketWatch64 · neutralm&a
Myriad Genetics to Divest Prenatal Testing Business
TipRanks44 · neutralm&a
Myriad Genetics to sell Prenatal Health testing business to Labcorp
The Fly58 · neutralm&a
MYRIAD GENETICS INC (MYGN) files 8-K
SEC 8-K50 · neutralgeneral
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
Business Insider64 · neutralm&a
Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
Barchart28 · bearishgeneral
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
Business Insider50 · neutralgeneral
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire50 · neutralgeneral
Myriad Genetics price target raised to $4.50 from $4 at TD Cowen
The Fly63 · neutralanalyst
MYRIAD GENETICS INC (MYGN) files 8-K
SEC 8-K50 · neutralgeneral
Myriad, SOPHiA partner with AstraZeneca to use prostate cancer technology
Seeking Alpha64 · neutralproduct/pr
Myriad, Sophia advance prostate cancer-specific genomic instability score tech
The Fly61 · neutralproduct/pr
Sophia Genetics and Myriad Genetics collaborate in prostate cancer score tech
The Fly63 · neutralproduct/pr